These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1216 related articles for article (PubMed ID: 26471778)

  • 21. Immunosuppressive cells and tumour microenvironment: focus on mesenchymal stem cells and myeloid derived suppressor cells.
    Bianchi G; Borgonovo G; Pistoia V; Raffaghello L
    Histol Histopathol; 2011 Jul; 26(7):941-51. PubMed ID: 21630223
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interaction of MSC with tumor cells.
    Melzer C; Yang Y; Hass R
    Cell Commun Signal; 2016 Sep; 14(1):20. PubMed ID: 27608835
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Current mechanistic insights into the roles of matrix metalloproteinases in tumour invasion and metastasis.
    Brown GT; Murray GI
    J Pathol; 2015 Nov; 237(3):273-81. PubMed ID: 26174849
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hallmarks of cancer: interactions with the tumor stroma.
    Pietras K; Ostman A
    Exp Cell Res; 2010 May; 316(8):1324-31. PubMed ID: 20211171
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Melanoma's connections to the tumour microenvironment.
    Brandner JM; Haass NK
    Pathology; 2013 Aug; 45(5):443-52. PubMed ID: 23851614
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tumor microenvironment-mediated chemoresistance in breast cancer.
    Velaei K; Samadi N; Barazvan B; Soleimani Rad J
    Breast; 2016 Dec; 30():92-100. PubMed ID: 27668856
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tumour-stromal interactions in breast cancer: the role of stroma in tumourigenesis.
    Kim JB; Stein R; O'Hare MJ
    Tumour Biol; 2005; 26(4):173-85. PubMed ID: 16006771
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Carcinoma-associated fibroblasts: non-neoplastic tumour-promoting mesenchymal cells.
    Polanska UM; Orimo A
    J Cell Physiol; 2013 Aug; 228(8):1651-7. PubMed ID: 23460038
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The tumour microenvironment as an integrated framework to understand cancer biology.
    Burgos-Panadero R; Lucantoni F; Gamero-Sandemetrio E; Cruz-Merino L; Álvaro T; Noguera R
    Cancer Lett; 2019 Oct; 461():112-122. PubMed ID: 31325528
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Is carcinoma a mesenchymal disease? The role of the stromal microenvironment in carcinogenesis.
    Hemmings C
    Pathology; 2013 Jun; 45(4):371-81. PubMed ID: 23594691
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunotherapy: target the stroma to hit the tumor.
    Kammertoens T; Schüler T; Blankenstein T
    Trends Mol Med; 2005 May; 11(5):225-31. PubMed ID: 15882610
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of stromal fibroblasts in cancer: promoting or impeding?
    Angeli F; Koumakis G; Chen MC; Kumar S; Delinassios JG
    Tumour Biol; 2009; 30(3):109-20. PubMed ID: 19440007
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression of E-cadherin repressors SNAIL, ZEB1 and ZEB2 by tumour and stromal cells influences tumour-budding phenotype and suggests heterogeneity of stromal cells in pancreatic cancer.
    Galván JA; Zlobec I; Wartenberg M; Lugli A; Gloor B; Perren A; Karamitopoulou E
    Br J Cancer; 2015 Jun; 112(12):1944-50. PubMed ID: 25989272
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tumor-stroma interactions directing phenotype and progression of epithelial skin tumor cells.
    Mueller MM; Fusenig NE
    Differentiation; 2002 Dec; 70(9-10):486-97. PubMed ID: 12492491
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pro-inflammatory chemokine-chemokine receptor interactions within the Ewing sarcoma microenvironment determine CD8(+) T-lymphocyte infiltration and affect tumour progression.
    Berghuis D; Santos SJ; Baelde HJ; Taminiau AH; Egeler RM; Schilham MW; Hogendoorn PC; Lankester AC
    J Pathol; 2011 Feb; 223(3):347-57. PubMed ID: 21171080
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tumour-stroma interactions between metastatic prostate cancer cells and fibroblasts.
    Kaminski A; Hahne JC; Haddouti el-M; Florin A; Wellmann A; Wernert N
    Int J Mol Med; 2006 Nov; 18(5):941-50. PubMed ID: 17016625
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cancer-associated-fibroblasts and tumour cells: a diabolic liaison driving cancer progression.
    Cirri P; Chiarugi P
    Cancer Metastasis Rev; 2012 Jun; 31(1-2):195-208. PubMed ID: 22101652
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Extracellular matrix secreted by reactive stroma is a main inducer of pro-tumorigenic features on LNCaP prostate cancer cells.
    Palumbo A; Ferreira LB; Reis de Souza PA; Oliveira FL; Pontes B; Viana NB; Machado DE; Palmero CY; Alves LM; Gimba ER; Nasciutti LE
    Cancer Lett; 2012 Aug; 321(1):55-64. PubMed ID: 22388175
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Therapeutic targeting of tumor-stroma interactions.
    Hiscox S; Barrett-Lee P; Nicholson RI
    Expert Opin Ther Targets; 2011 May; 15(5):609-21. PubMed ID: 21388336
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fibroblast and prostate tumor cell cross-talk: fibroblast differentiation, TGF-β, and extracellular matrix down-regulation.
    Coulson-Thomas VJ; Gesteira TF; Coulson-Thomas YM; Vicente CM; Tersariol IL; Nader HB; Toma L
    Exp Cell Res; 2010 Nov; 316(19):3207-26. PubMed ID: 20727350
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 61.